These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1676448)

  • 41. Can CSF measures distinguish among schizophrenia, depression, movement disorders, and dementia?
    Stahl SM
    Psychopharmacol Bull; 1985; 21(3):396-9. PubMed ID: 2863846
    [No Abstract]   [Full Text] [Related]  

  • 42. S-adenosylmethionine and depression.
    Nguyen M; Gregan A
    Aust Fam Physician; 2002 Apr; 31(4):339-43. PubMed ID: 12043126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropsychological profile linked to low dopamine: in Alzheimer's disease, major depression, and Parkinson's disease.
    Wolfe N; Katz DI; Albert ML; Almozlino A; Durso R; Smith MC; Volicer L
    J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):915-7. PubMed ID: 2266376
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CSF cortisol in affective illness.
    Gerner RH; Wilkins JN
    Psychiatr Med; 1985; 3(1):33-40. PubMed ID: 3843451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transmethylation in depression.
    Bottiglieri T; Chary TK; Laundy M; Carney MW; Godfrey P; Toone BK; Reynolds EH
    Ala J Med Sci; 1988 Jul; 25(3):296-301. PubMed ID: 3052137
    [No Abstract]   [Full Text] [Related]  

  • 46. Homocysteine, folate, methylation, and monoamine metabolism in depression.
    Bottiglieri T; Laundy M; Crellin R; Toone BK; Carney MW; Reynolds EH
    J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):228-32. PubMed ID: 10896698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.
    Becker A; Vezmar S; Linnebank M; Pels H; Bode U; Schlegel U; Jaehde U
    Int J Clin Pharmacol Ther; 2007 Sep; 45(9):504-15. PubMed ID: 17907593
    [TBL] [Abstract][Full Text] [Related]  

  • 48. S-adenosyl-L-methionine for treatment of depression, osteoarthritis, and liver disease.
    Hardy ML; Coulter I; Morton SC; Favreau J; Venuturupalli S; Chiappelli F; Rossi F; Orshansky G; Jungvig LK; Roth EA; Suttorp MJ; Shekelle P
    Evid Rep Technol Assess (Summ); 2003 Aug; (64):1-3. PubMed ID: 12899148
    [No Abstract]   [Full Text] [Related]  

  • 49. Elevation of substance P-like peptides in the CSF of psychiatric patients.
    Rimón R; Le Grevés P; Nyberg F; Heikkilä L; Salmela L; Terenius L
    Biol Psychiatry; 1984 Apr; 19(4):509-16. PubMed ID: 6203562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta.
    Oikonomidi A; Lewczuk P; Kornhuber J; Smulders Y; Linnebank M; Semmler A; Popp J
    J Neurochem; 2016 Oct; 139(2):324-332. PubMed ID: 27507672
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Complementary and alternative medicine for the treatment of depressive disorders in women.
    Deligiannidis KM; Freeman MP
    Psychiatr Clin North Am; 2010 Jun; 33(2):441-63. PubMed ID: 20385346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Suicide attempt by self-burning associated with ingestion of S-adenosylmethionine: a review of the literature and case report.
    Chitiva H; Audivert F; Alvarez C
    J Nerv Ment Dis; 2012 Jan; 200(1):99-101. PubMed ID: 22210371
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical evaluation of the antidepressive action of sulfoadenosyl-L-methionine compared with that of chlorimipramine].
    Giner Ubago J; González Infante JM; Blanco Picabia A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):73-80. PubMed ID: 6372376
    [No Abstract]   [Full Text] [Related]  

  • 54. Monitoring S-adenosyl-methionine blood levels and antidepressant effect.
    Del Vecchio M; Amati A; Vacca L; Zizolfi S
    Acta Neurol (Napoli); 1980 Dec; 2(6):488-95. PubMed ID: 7027755
    [No Abstract]   [Full Text] [Related]  

  • 55. Elevation of immunoreactive CSF TRH in depressed patients.
    Banki CM; Bissette G; Arato M; Nemeroff CB
    Am J Psychiatry; 1988 Dec; 145(12):1526-31. PubMed ID: 3143269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A study of abnormal CSF total proteins and immunoglobulins levels in patients of depression.
    Kumar A; Tewari SC; Lal N; Trivedi JK; Bahuguna LM
    Indian J Physiol Pharmacol; 1986; 30(1):103-6. PubMed ID: 3818025
    [No Abstract]   [Full Text] [Related]  

  • 57. An open-label pilot study of oral S-adenosyl-L-methionine in major depression: interim results.
    Rosenbaum JF; Fava M; Falk WE; Pollack MH; Cohen LS; Cohen BM; Zubenko GS
    Psychopharmacol Bull; 1988; 24(1):189-94. PubMed ID: 3387521
    [No Abstract]   [Full Text] [Related]  

  • 58. CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa.
    Gerner RH; Hare TA
    Am J Psychiatry; 1981 Aug; 138(8):1098-101. PubMed ID: 7258390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    Bougea A; Stefanis L; Paraskevas GP; Emmanouilidou E; Efthymiopoulou E; Vekrelis K; Kapaki E
    J Neurol; 2018 Oct; 265(10):2295-2301. PubMed ID: 30083953
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental Pharmacology in Transgenic Rodent Models of Alzheimer's Disease.
    Cuello AC; Hall H; Do Carmo S
    Front Pharmacol; 2019; 10():189. PubMed ID: 30886583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.